Healthcare -
Biotechnology - NYSE - DK
$ 85.25
-0.105 %
$ 372 B
Market Cap
28.8
P/E
NVO - TOTAL RECEIVABLES
Total Receivables NVO - Novo Nordisk A/S
75.3 B
LAST VALUE
26.81%
2 YEAR CAGR
22.86%
5 YEAR CAGR
21.31%
10 YEAR CAGR